Therapies

SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D

11 days ago   |   By Xconomy

SQZ Biotechnologies, which already has an alliance with Roche focused on developing new cancer cell therapies, is now looking to sell shares to the public to finance its research of potential new treatments for both cancer and infectious disease. In paperwork filed with securities regulators late last week, SQZ set a preliminary $75 million goal for its IPO. The Watertown, MA-based biotech has applied for a listing on the New York Stock Exchange under the stock symbol “SQZ.” SQZ is developing technology intended to improve cell therapy. Current cell therapies get the therapeutic cargo into...
Read more ...

 


Search by Tags

   Therapies      Research      R&D      Applied      Biotech      BioTech      Therapeutics      BioTechnology      Cancer      Boston      Boston blog main      Boston top stories      National blog main      National top stories      New York blog main      San Francisco blog main      AIG DECO Fund      Armon Sharei      Cancer      Cancer cell therapy      Cell Therapy      Clinical trials      Elbrus Investments      FDA      Klavs Jensen      Life Sciences      MIT Robert Langer      Polaris Partners      Roche      SQZ Biotechnologies  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Software-as-a-Service, Use The Power Of The Cloud For Your Company

Software-as-a-Service, Use The Power Of The Cloud For Your Company

Written By: Andrea Salive, Business Development Manager Question: when was the last time you left your house without your cell phone? Or asked your friend, hotel concierge or... Read more ...

Puracyp: Research Assistant

$20-30/hr. Some benefits: Puracyp: LABORATORY TECHNICIAN/RESEARCH ASSISTANT in a small biotech company. Tissue Culture experience necessary. San Diego CA ... Read more ...

Gilead Sciences, Inc.: Sr. Associate Scientist )

Gilead Sciences, Inc.: Sr. Associate Scientist ) United States - California - Oceanside Gilead Sciences, Inc. is a research-based bio-ph Oceanside, CA, US ... Read more ...

Overexpression of GmMYB14 improves high‐density yield and drought tolerance...

Summary MYB transcription factors have been reported to regulate the biosynthesis of secondary metabolites, as well as to mediate plant adaption to abiotic stresses, including... Read more ...

The Celery Genome Sequence Reveals Sequential Paleo‐Polyploidizations...

Summary Celery , a member of the Apiaceae family, is among the most important and globally grown vegetables. Here, we report a high‐quality genome sequence assembly, anchored... Read more ...

Microbiome‐wide association studies reveal correlations between the...

Summary Cassava is one of the most important staple food crops in tropical regions. To date, an understanding of the relationship between microbial communities and disease... Read more ...

Enhancement of CRISPR-Cas9 induced precise gene editing by targeting histone...

Precise genetic modifications are preferred products of CRISPR-Cas9 mediated gene editing in mammalian cells but require the repair of induced double-strand breaks through... Read more ...

A rank-based marker selection method for high throughput scRNA-seq data

High throughput microfluidic protocols in single cell RNA sequencing collect mRNA counts from up to one million individual cells in a single experiment; this enables high... Read more ...

Retrophin: Senior Director, Clinical Science

Retrophin: Clinical Dev - Renal Location: San Diego Position Summary: The Senior Director, Clinical Science is an integral member of the Cl San Diego, California ... Read more ...

KSQ boosts PARP inhibition in animal models of ovarian and breast cancers...

KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor arlene.weintraub Fri, 10/23/2020 - 10:03 Read more ...